(Q34098560)

31 July 2017

title

Immunotherapy of hepatoma with a monoclonal antibody against murine endoglin (English)

1 reference

31 July 2017

1 reference

hepatocellular carcinoma

1 reference

1 reference

Guang-Hong Tan

1

1 reference

31 July 2017

Feng-Ying Huang

2

1 reference

31 July 2017

Hua Wang

3

1 reference

31 July 2017

Yong-Hao Huang

4

1 reference

31 July 2017

Ying-Ying Lin

5

1 reference

31 July 2017

Yue-Nan Li

6

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 May 2007

1 reference

World Journal of Gastroenterology

31 July 2017

published in

1 reference

31 July 2017

volume

13

1 reference

31 July 2017

issue

17

1 reference

31 July 2017

page(s)

2479-2483

1 reference

describes a project that uses

31 July 2017

1 reference

A plasmid DNA vaccine encoding the extracellular domain of porcine endoglin induces anti-tumour immune response against self-endoglin-related angiogenesis in two liver cancer models

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4146767

Vascular targeting agents as cancer therapeutics

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4146767

Emerging role of endoglin (CD105) as a marker of angiogenesis with clinical potential in human malignancies.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4146767

Mechanism and its regulation of tumor-induced angiogenesis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4146767

CD105 is important for angiogenesis: evidence and potential applications

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4146767

Global cancer statistics in the year 2000.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4146767

Immunogene therapy of tumors with vaccine based on Xenopus homologous vascular endothelial growth factor as a model antigen

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4146767

Estimates of the worldwide mortality from 25 cancers in 1990.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4146767

Targeting endothelium for gene therapy via receptors up-regulated during angiogenesis and inflammation

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4146767

Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4146767

Mechanisms of angiogenesis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4146767

Antibody-directed targeting of the vasculature of solid tumors

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4146767

Angiogenesis, neovascular proliferation and vascular pathophysiology as targets for cancer therapy

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4146767

Differentiation of endothelium.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4146767

Distinct human leukemia-associated cell surface glycoprotein GP160 defined by monoclonal antibody SN6.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4146767

Inhibition of tumor angiogenesis as a strategy to circumvent acquired resistance to anti-cancer therapeutic agents

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4146767

Structure of solid tumors and their vasculature: implications for therapy with monoclonal antibodies

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4146767

What Is the Evidence That Tumors Are Angiogenesis Dependent?

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4146767

Active immunotherapy of tumors with a recombinant xenogeneic endoglin as a model antigen

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4146767

Synergy between anti-endoglin (CD105) monoclonal antibodies and TGF-beta in suppression of growth of human endothelial cells.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4146767

Long-lasting complete inhibition of human solid tumors in SCID mice by targeting endothelial cells of tumor vasculature with antihuman endoglin immunotoxin.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4146767

Angiogenesis inhibition: a review

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4146767

Cell turnover of capillaries

28 October 2018

1 reference

12 December 2020

Identification of a human endothelial cell antigen with monoclonal antibody 44G4 produced against a pre-B leukemic cell line

1 reference

12 December 2020

1 reference

12 December 2020

Barriers to drug delivery in solid tumors

1 reference

12 December 2020

Differential expression of endoglin on fetal and adult hematopoietic cells in human bone marrow

1 reference

12 December 2020

Angiogenesis: a critical process in the pathogenesis of RA--a role for VEGF?

1 reference

12 December 2020

A highly sensitive model for quantification of in vivo tumor angiogenesis induced by alginate-encapsulated tumor cells

1 reference

12 December 2020

Up-regulation of endoglin on vascular endothelial cells in human solid tumors: implications for diagnosis and therapy

1 reference

12 December 2020

Induction of lasting complete regression of preformed distinct solid tumors by targeting the tumor vasculature using two new anti-endoglin monoclonal antibodies

1 reference

12 December 2020

Hepatocellular carcinoma

1 reference

12 December 2020

Inhibition of tumor growth with a vaccine based on xenogeneic homologous fibroblast growth factor receptor-1 in mice

1 reference

12 December 2020

Identifiers

DOI

10.3748/WJG.V13.I17.2479

1 reference

release_jazfudtqrneyfeogsgu7rizqki

31 July 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/jazfudtqrneyfeogsgu7rizqki

24 November 2022

mapped directly with Wikidata item

PMC publication ID

4146767

1 reference

31 July 2017

1 reference